Currently, the healthcare and pharma industries are valued at a colossal $372 billion and $50 billion, respectively. As one of the largest employers, employing around 7.5 million people, the healthcare sector is undeniably the country’s economic backbone. Amid this competitive landscape, it’s imperative for existing professionals and those aspiring to build a career in the healthcare/pharma industry to upskill themselves regularly. Let’s delve into the skills and salary trends over the past five years in the healthcare and pharma sectors.
Evolving Skillsets
The healthcare and pharmaceutical industries are undergoing profound transformations, led by the adoption of artificial intelligence (AI), telemedicine, automation, and data analytics. These innovations are reshaping the workforce, creating demand for roles like data scientists, AI specialists, and platform engineers. A recent report forecasts that these technological shifts will generate 2.7 to 3.5 million new jobs by 2027, even as they replace about 23 per cent of existing positions.
Between 2020 and 2024, salaries for fresher roles in these sectors increased from Rs 1.7 lakh per annum to Rs 2.2 lakh per annum, while lateral roles saw stable compensation levels around Rs 9.9 lakh per annum. Technology-specific roles such as AI engineers, machine learning experts, and data scientists have witnessed higher growth in salaries, with entrylevel positions starting at Rs 9.6 to 10.2 lakh per annum and senior positions commanding over Rs 24 lakh per annum. However, despite a general salary increase of 9-10 per cent annually, disparities remain. Factors like company size, location, and specialisation play crucial roles in determining compensation. Urban hubs like Bengaluru and Hyderabad offer higher salaries, reflecting their status as tech-driven healthcare hubs.
This story is from the BioSpectrum India Jan 2025 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum India Jan 2025 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Parse Biosciences announces expansion of Evercode BCR product line
Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
RSSDI study lays focus on Yoga and Diabetes Prevention
Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.